6052 | BioNTech phase 2 (Walsh), 2020 | 2 | 1 | 0 | excluded | risk of bias not avaialble | |
6766 | Pfizer 16-25 years phase 3, 0 | 2 | 1 | 0 | excluded | risk of bias not avaialble | |
9230 | Burns, 2022 | 2 | 0 | 0 | excluded | risk of bias not avaialble | |
9445 | Kawasuji, 2022 | 2 | 0 | 0 | excluded | risk of bias not avaialble | |
9466 | Falsey, 0 | 2 | 0 | 0 | excluded | risk of bias not avaialble | |
9485 | Molteni, 2022 | 2 | 0 | 0 | excluded | risk of bias not avaialble |